{"title":"[儿童流感疫苗接种的有效性和安全性:一项系统综述]。","authors":"F M Escandell Rico, L Pérez Fernández","doi":"10.37201/req/101.2023","DOIUrl":null,"url":null,"abstract":"<p><strong>Objective: </strong>Children are at a higher risk of influenza infection compared to the general population. The World Organization Health and recommendations of the Vaccine Advisory Committee of the Spanish Association of Pediatrics contemplate annual vaccination as the most effective way to prevent the disease. Therefore, the purpose of this review was to update information on efficacy and safety in the anti -shed vaccine in children and adolescents.</p><p><strong>Methods: </strong>A search in four electronic databases (Scopus, Cumulative Index to Nursing and Allied Health Literature, Medline / Pubmed, Google Scholar and Cochrane), as well as a manual search to identify original research published between 2012 and 2022. The guidelines of ANALYSIS (PRISMACR) as a preferred report element for systematic reviews.</p><p><strong>Results: </strong>Seven original research articles were included where two issues of antigripal vaccination were identified in healthy children/adolescents and with pathologies. The efficacy (between approximately 30% and 80%) varied depending on the vaccine used and circulating subtypes. Most adverse reactions were mild intensity, and the most common local adverse event was pain in the injection site.</p><p><strong>Conclusions: </strong>We positively highlight the safety of pediatric flu vaccination in analyzed studies, on the contrary, with respect to the efficacy of flu vaccination, we observe a wide variability of results. There is a clear need to continue conducting efficacy and safety studies in the child.</p>","PeriodicalId":94198,"journal":{"name":"Revista espanola de quimioterapia : publicacion oficial de la Sociedad Espanola de Quimioterapia","volume":" ","pages":"43-51"},"PeriodicalIF":0.0000,"publicationDate":"2024-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10874658/pdf/","citationCount":"0","resultStr":"{\"title\":\"[Efficacy and safety of pediatric flu vaccination: a systematic review].\",\"authors\":\"F M Escandell Rico, L Pérez Fernández\",\"doi\":\"10.37201/req/101.2023\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Objective: </strong>Children are at a higher risk of influenza infection compared to the general population. The World Organization Health and recommendations of the Vaccine Advisory Committee of the Spanish Association of Pediatrics contemplate annual vaccination as the most effective way to prevent the disease. Therefore, the purpose of this review was to update information on efficacy and safety in the anti -shed vaccine in children and adolescents.</p><p><strong>Methods: </strong>A search in four electronic databases (Scopus, Cumulative Index to Nursing and Allied Health Literature, Medline / Pubmed, Google Scholar and Cochrane), as well as a manual search to identify original research published between 2012 and 2022. The guidelines of ANALYSIS (PRISMACR) as a preferred report element for systematic reviews.</p><p><strong>Results: </strong>Seven original research articles were included where two issues of antigripal vaccination were identified in healthy children/adolescents and with pathologies. The efficacy (between approximately 30% and 80%) varied depending on the vaccine used and circulating subtypes. Most adverse reactions were mild intensity, and the most common local adverse event was pain in the injection site.</p><p><strong>Conclusions: </strong>We positively highlight the safety of pediatric flu vaccination in analyzed studies, on the contrary, with respect to the efficacy of flu vaccination, we observe a wide variability of results. There is a clear need to continue conducting efficacy and safety studies in the child.</p>\",\"PeriodicalId\":94198,\"journal\":{\"name\":\"Revista espanola de quimioterapia : publicacion oficial de la Sociedad Espanola de Quimioterapia\",\"volume\":\" \",\"pages\":\"43-51\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2024-02-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10874658/pdf/\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Revista espanola de quimioterapia : publicacion oficial de la Sociedad Espanola de Quimioterapia\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.37201/req/101.2023\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2023/12/5 0:00:00\",\"PubModel\":\"Epub\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Revista espanola de quimioterapia : publicacion oficial de la Sociedad Espanola de Quimioterapia","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.37201/req/101.2023","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2023/12/5 0:00:00","PubModel":"Epub","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
摘要
目的:与普通人群相比,儿童感染流感的风险更高。世界卫生组织和西班牙儿科协会疫苗咨询委员会的建议认为,每年接种疫苗是预防该病的最有效方法。因此,本综述的目的是更新儿童和青少年抗牛痘疫苗的有效性和安全性信息。方法:检索四个电子数据库(Scopus, Cumulative Index to Nursing and Allied Health Literature, Medline / Pubmed, Google Scholar和Cochrane),以及人工检索2012年至2022年间发表的原始研究。分析指南(PRISMACR)作为系统审查的首选报告元素。结果:纳入了7篇原创研究文章,其中在健康儿童/青少年和病理中确定了抗耳垢疫苗接种的两个问题。效力(大约在30%到80%之间)因所使用的疫苗和流行亚型而异。不良反应多为轻度,最常见的局部不良反应为注射部位疼痛。结论:我们在分析的研究中积极强调儿童流感疫苗接种的安全性,相反,在流感疫苗接种的有效性方面,我们观察到结果的差异很大。显然有必要继续对儿童进行有效性和安全性研究。
[Efficacy and safety of pediatric flu vaccination: a systematic review].
Objective: Children are at a higher risk of influenza infection compared to the general population. The World Organization Health and recommendations of the Vaccine Advisory Committee of the Spanish Association of Pediatrics contemplate annual vaccination as the most effective way to prevent the disease. Therefore, the purpose of this review was to update information on efficacy and safety in the anti -shed vaccine in children and adolescents.
Methods: A search in four electronic databases (Scopus, Cumulative Index to Nursing and Allied Health Literature, Medline / Pubmed, Google Scholar and Cochrane), as well as a manual search to identify original research published between 2012 and 2022. The guidelines of ANALYSIS (PRISMACR) as a preferred report element for systematic reviews.
Results: Seven original research articles were included where two issues of antigripal vaccination were identified in healthy children/adolescents and with pathologies. The efficacy (between approximately 30% and 80%) varied depending on the vaccine used and circulating subtypes. Most adverse reactions were mild intensity, and the most common local adverse event was pain in the injection site.
Conclusions: We positively highlight the safety of pediatric flu vaccination in analyzed studies, on the contrary, with respect to the efficacy of flu vaccination, we observe a wide variability of results. There is a clear need to continue conducting efficacy and safety studies in the child.